Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTCT | CRNX | CPRX | ||
| Company | Ptc Therapeutics | Crinetics Pharmaceuticals Inc | Catalyst Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.77 | 52.28 | 21.27 | ||
| High | 47.42 | 54.25 | 21.41 | ||
| Low | 44.74 | 51.73 | 21.01 | ||
| Last | 46.24 | 53.60 | 21.27 | ||
| Change | +0.99 | +0.86 | -0.19 | ||
| % Change | +2.19% | +1.63% | -0.89% | ||
| Volume | 1,431,600 | 1,940,400 | 1,753,300 | ||
| 20-Day Average Volume | 916,160 | 760,260 | 916,435 | ||
| Previous Close | 45.25 | 52.74 | 21.46 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.20 | 56.15 | 21.76 | ||
| 20-Day Raw Stochastic | 30.65% | 29.24% | 16.27% | ||
| 20-Day Relative Strength | 53.19% | 45.12% | 47.67% | ||
| Weighted Alpha | +75.76 | +34.17 | +33.38 | ||
| Today's Opinion | 88% Buy | 24% Buy | 72% Buy | ||
| Previous Opinion | 88% Buy | 24% Buy | 72% Buy | ||
| Last Month's Opinion | 96% Buy | 80% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.28% since 12/13/24 | -0.11% since 12/13/24 | -0.51% since 12/13/24 | ||
| Low | 44.30 on 12/18/24 | 50.81 on 12/19/24 | 21.01 on 12/20/24 | ||
| High | 48.77 on 12/16/24 | 56.15 on 12/17/24 | 22.67 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +10.20% since 11/20/24 | -4.41% since 11/20/24 | +0.57% since 11/20/24 | ||
| Low | 41.21 on 11/21/24 | 50.81 on 12/19/24 | 20.87 on 11/21/24 | ||
| High | 54.16 on 12/03/24 | 60.34 on 12/11/24 | 23.02 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +26.20% since 09/20/24 | +0.85% since 09/20/24 | +2.31% since 09/20/24 | ||
| Low | 34.57 on 10/07/24 | 49.13 on 09/24/24 | 19.35 on 09/30/24 | ||
| High | 54.16 on 12/03/24 | 62.53 on 11/14/24 | 24.27 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +38.90% since 06/20/24 | +21.24% since 06/20/24 | +40.12% since 06/20/24 | ||
| Low | 28.72 on 06/28/24 | 41.01 on 06/26/24 | 14.75 on 06/26/24 | ||
| High | 54.16 on 12/03/24 | 62.53 on 11/14/24 | 24.27 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,566,260 | 4,970,756 | 2,536,937 | ||
| Shares Outstanding, K | 77,125 | 92,738 | 119,273 | ||
| Annual Sales | 937,820,000 | 4,010,000 | 398,200,000 | ||
| Annual Net Income | -626,600,000 | -214,530,000 | 71,410,000 | ||
| Last Quarter Sales | 196,790,000 | 400,000 | 128,700,000 | ||
| Last Quarter Net Income | -106,650,000 | -74,050,000 | 43,880,000 | ||
| 60-Month Beta | 0.63 | 0.60 | 0.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.39 on 11/07/24 | -0.96 on 11/12/24 | 0.57 on 11/06/24 | ||
| Latest Earnings Date | 11/07/24 | 11/12/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.50 | ||